We are live on ! Find out more
FOMX

Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX

Delisted

FOMX was delisted on the 6th of March, 2020.

Back to rankings

31 hedge funds and large institutions have $68.7M invested in Foamix Pharmaceuticals Ltd. Ordinary Shares in 2015 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 3

89% more capital invested

Capital invested by funds: $36.4M → $68.7M (+$32.3M)

50% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 6

48% more funds holding

Funds holding: 21 → 31 (+10)

Holders
31
Holders Change
+10
Holders Change %
+47.62%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
13
Increased
9
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$7.16M
2
DA
DSC Advisors
Illinois
+$5.4M
3
Jennison Associates
Jennison Associates
New York
+$4.3M
4
MMH
Menora Mivtachim Holdings
Israel
+$3.64M
5
SFM
Sphera Funds Management
Israel
+$1.79M

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$5.14M
2
SM
Sabby Management
Florida
-$1.32M
3
PCM
Pentwater Capital Management
Florida
-$626K
4
DM
Deerfield Management
New York
-$583K
5
Deutsche Bank
Deutsche Bank
Germany
-$241K
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$16.9M +$7.16M +800,367 +78%
Jennison Associates
2
Jennison Associates
New York
$10.1M +$4.3M +480,847 +79%
DA
3
DSC Advisors
Illinois
$8.06M +$5.4M +603,343 +225%
PCM
4
Pentwater Capital Management
Florida
$6.29M -$626K -70,000 -9%
DM
5
Deerfield Management
New York
$6.29M -$583K -65,172 -9%
SAM
6
Senzar Asset Management
New York
$5.26M +$500K +55,900 +11%
MMH
7
Menora Mivtachim Holdings
Israel
$3.77M +$3.64M +407,121 New
DCM
8
Driehaus Capital Management
Illinois
$2.97M +$958K +107,062 +50%
Alyeska Investment Group
9
Alyeska Investment Group
Illinois
$1.86M +$132K +14,781 +8%
SFM
10
Sphera Funds Management
Israel
$1.85M +$1.79M +200,000 New
AC
11
Ascend Capital
California
$1.15M +$1.11M +124,551 New
FAM
12
Fred Alger Management
New York
$634K +$613K +68,500 New
MC
13
Menta Capital
California
$606K +$587K +65,559 New
Federated Hermes
14
Federated Hermes
Pennsylvania
$555K +$89.5K +10,000 +20%
Millennium Management
15
Millennium Management
New York
$526K +$509K +56,900 New
Acadian Asset Management
16
Acadian Asset Management
Massachusetts
$422K +$409K +45,692 New
PAM
17
Panagora Asset Management
Massachusetts
$230K +$222K +24,814 New
AAP
18
Ardsley Advisory Partners
Connecticut
$185K +$89.5K +10,000 +100%
BFA
19
BlackRock Fund Advisors
California
$178K +$103K +11,464 +147%
SIM
20
Spark Investment Management
New York
$156K -$671 -75 -0.4%
SM
21
Sabby Management
Florida
$142K -$1.32M -148,000 -91%
Morgan Stanley
22
Morgan Stanley
New York
$139K -$8.23K -920 -6%
B
23
Baird
Wisconsin
$139K +$134K +15,000 New
PPCM
24
Pillar Pacific Capital Management
California
$129K +$125K +14,000 New
ARTA
25
A.R.T. Advisors
New York
$123K -$5.13K -573 -4%
1
2

FOMX Hedge Fund Activity: Q1 2015 in Review

31 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) for Q1 2015, worth a combined $68.7M — up 89% from $36.4M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new FOMX positions and 3 closed out — a net gain of 10 holders — while 9 added to existing stakes and 6 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $7.16M. The largest seller was JP Morgan Chase, exiting entirely with an estimated $5.14M sold.

  • 31 institutional investors held Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) as of Q1 2015, up from 21 in Q4 2014.
  • Funds reported $68.7M of Foamix Pharmaceuticals Ltd. Ordinary Shares stock for Q1 2015, up 89% quarter-over-quarter.
  • 13 funds opened new Foamix Pharmaceuticals Ltd. Ordinary Shares positions in Q1 2015 and 3 closed out, a net change of +10 holders.
  • The largest Foamix Pharmaceuticals Ltd. Ordinary Shares buyer in Q1 2015 was Baker Bros. Advisors, an estimated $7.16M added.
  • The largest Foamix Pharmaceuticals Ltd. Ordinary Shares seller in Q1 2015 was JP Morgan Chase, an estimated $5.14M sold.

Based on aggregated 13F filings for Q1 2015.